The FDA approved Vantrela and Troxyca, two abuse-deterrent opioids, but also asked the medical community for better evaluations on abuse-deterrence, according to MedPage Today.
Here are three insights:
1. The Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety Risk Management Advisory Committee approved the two drugs.
2. The panel voted 14 to 3 on Vantrela, and 9 to 6 on Troxyca.
3. Vantrela is an abuse-deterrent formulation of extended-release hydrocodone. Troxyca is an abuse-deterrent formulation of extended-release oxycodone with naltrexone.
